Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

48.8K
Overview
48.8K
Cancer Vaccines01:30

Cancer Vaccines

603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.1K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.

Biomolecules·2026
Same author

Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells.

Clinical & translational immunology·2026
Same author

A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains.

Bioorganic chemistry·2026
Same author

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.

NPJ vaccines·2026
Same author

Veterinary Forensic Pathology in the Investigation of Animal Cruelty: Post-Mortem Insights, Forensic Tools, Case Studies, and Legal Perspectives.

Animals : an open access journal from MDPI·2026
Same author

The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

Veterinary sciences·2026

Related Experiment Video

Updated: Nov 8, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.4K

A Potent Vaccine Delivery System.

Guangzu Zhao1, Armira Azuar1, Istvan Toth1,2,3

  • 1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Australia.

Bio-Protocol
|April 23, 2021
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel, biodegradable, and non-toxic self-adjuvanting vaccine delivery system. This system, made from polyleucine-conjugated peptide antigens assembled into nanoparticles, enhances immune responses effectively.

Keywords:
Delivery systemParticle self-assemblyPeptide synthesisPoly (hydrophobic amino acid)PolyleucineSecondary structureSelf-adjuvanting nanoparticlesSubunit vaccine

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Related Experiment Videos

Last Updated: Nov 8, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.4K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K

Area of Science:

  • Vaccine Adjuvants and Delivery Systems
  • Nanotechnology in Immunology
  • Bioconjugation Chemistry

Background:

  • Effective vaccines often require adjuvants to stimulate robust immune responses.
  • Current adjuvants face limitations including poor biodegradability, limited efficacy, and adverse safety profiles.
  • There is a critical need for advanced adjuvant systems or self-adjuvanting vaccine platforms.

Purpose of the Study:

  • To develop a fully defined, biodegradable, and non-toxic self-adjuvanting vaccine delivery system.
  • To create a novel platform for enhancing peptide antigen immunogenicity.
  • To provide a detailed protocol for the production and characterization of this new system.

Main Methods:

  • Conjugation of polyleucine to peptide antigens via solid-phase peptide synthesis.
  • Self-assembly of the polyleucine-peptide conjugate into well-defined nanoparticles.
  • Purification and comprehensive physicochemical characterization of the resulting nanovaccine system.

Main Results:

  • Successful synthesis and characterization of a novel polyleucine-peptide conjugate.
  • Demonstration of self-assembly into uniform nanoparticles with defined physicochemical properties.
  • Establishment of a reproducible protocol for producing a self-adjuvanting vaccine delivery system.

Conclusions:

  • The developed polyleucine-based nanoparticle system offers a promising biodegradable and non-toxic alternative to conventional adjuvants.
  • This self-adjuvanting delivery system effectively enhances peptide antigen presentation and potential immunogenicity.
  • The detailed protocol facilitates the reproducible production of advanced nanovaccine formulations.